- Report
- December 2024
- 200 Pages
Global
From €2340EUR$2,500USD£1,956GBP
- Report
- April 2025
- 85 Pages
Saudi Arabia
From €3276EUR$3,500USD£2,738GBP
- Report
- May 2024
- 185 Pages
Global
From €4212EUR$4,500USD£3,520GBP
- Report
- January 2025
- 82 Pages
India
From €3276EUR$3,500USD£2,738GBP
- Drug Pipelines
- April 2025
- 70 Pages
Global
From €1404EUR$1,500USD£1,173GBP
- Report
- July 2024
- 100 Pages
Global
From €3510EUR$3,750USD£2,934GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1872EUR$2,000USD£1,565GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1404EUR$1,500USD£1,173GBP
- Report
- July 2025
- 215 Pages
Global
From €4675EUR$4,995USD£3,908GBP
- Report
- November 2025
- 150 Pages
Global
From €4539EUR$4,850USD£3,794GBP
- Report
- April 2025
- 150 Pages
Global
From €4539EUR$4,850USD£3,794GBP
- Report
- March 2025
- 150 Pages
Global
From €4539EUR$4,850USD£3,794GBP
- Report
- October 2025
- 160 Pages
Global
From €2958EUR$3,160USD£2,472GBP
€3697EUR$3,950USD£3,090GBP
- Report
- October 2025
- 160 Pages
Global
From €2958EUR$3,160USD£2,472GBP
€3697EUR$3,950USD£3,090GBP
- Report
- October 2025
- 160 Pages
Global
From €2958EUR$3,160USD£2,472GBP
€3697EUR$3,950USD£3,090GBP
- Report
- August 2025
- 150 Pages
Global
From €2958EUR$3,160USD£2,472GBP
€3697EUR$3,950USD£3,090GBP
- Report
- November 2024
- 203 Pages
Global
From €4165EUR$4,450USD£3,481GBP
- Report
- February 2022
- 180 Pages
Global
From €4165EUR$4,450USD£3,481GBP
- Report
- April 2021
Global
From €4165EUR$4,450USD£3,481GBP
- Report
- November 2022
- 288 Pages
Global
From €3369EUR$3,600USD£2,816GBP

The Carbapenem market is a subset of the Antibiotics market, which is composed of drugs used to treat bacterial infections. Carbapenems are a class of antibiotics that are used to treat serious infections caused by bacteria that are resistant to other antibiotics. They are typically used as a last resort when other antibiotics have failed. Carbapenems are generally well-tolerated and have a low risk of side effects.
Carbapenems are used to treat a wide range of infections, including pneumonia, urinary tract infections, and skin and soft tissue infections. They are also used to treat infections caused by multidrug-resistant bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA).
The Carbapenem market is highly competitive, with several major players. These include Merck & Co., Pfizer, GlaxoSmithKline, AstraZeneca, and Sanofi. Other companies in the market include Allergan, Novartis, and Daiichi Sankyo. Show Less Read more